Could a shot plus a vaccine stop malaria in babies?
NCT ID NCT06461026
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 32 times
Summary
This study tests whether giving infants an experimental antibody (L9LS) before a malaria vaccine is safe and helps the vaccine work better. About 180 babies in Mali, aged 1 to 12 months, will receive either L9LS or a placebo, then the R21/Matrix-M vaccine. Researchers will monitor side effects and measure immune responses to see if this combination improves protection against malaria.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faladje MRTC Clinic
Faladié, Koulikoro, Mali
-
Kalifabougou MRTC Clinic
Kalifabougou, Koulikoro, Mali
-
Torodo MRTC Clinic
Torodo, Koulikoro, Mali
Conditions
Explore the condition pages connected to this study.